(6RS)-LOXO-195 (BAY 2731954) is a highly potent and selective inhibitor of the Trk family of tyrosine kinases. It is utilized in biochemical and cellular research to investigate Trk-driven oncogenesis and has demonstrated antitumor activity in preclinical in vivo models of NTRK-rearranged cancers.